CING · Insider Trading
Cingulate Inc. Common Stock
Every open-market purchase and sale reported by CING officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Raul R. Silva | EVP and CSO | A | +4,293 deriv. | — |
| 2026-07-20 | Thomas Jeffrey Hargroves | Director | A | +20,000 deriv. | — |
| 2026-07-20 | Matthew Brams | EVP and Chief Medical Officer | A | +80,000 deriv. | — |
| 2026-07-20 | Jennifer L. Callahan | EVP and CFO | A | +60,000 deriv. | — |
| 2026-07-20 | Bryan Jay Lawrence | Director | A | +20,000 deriv. | — |
| 2026-07-20 | Bryan Wade Downey | EVP & Chief Commercial Officer | A | +100,000 deriv. | — |
| 2026-07-20 | Peter J. Werth | Director | A | +20,000 deriv. | — |
| 2026-07-20 | Raul R. Silva | EVP and CSO | A | +80,000 deriv. | — |
| 2026-07-20 | Shane J. Schaffer | Chief Executive Officer | A | +295,000 deriv. | — |
| 2026-07-02 | Raul R. Silva | EVP and CSO | A | +3,885 deriv. | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CING quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.